Licensing as a commercialisation strategy for new technology-based firms

Research Policy

Volumn 33, Issue 8, 2004, Pages 1141-1151

  Kollmer, Holger ^a   Dowling, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Biotech industry; Licensing strategy; Technology transfer; Technology based firms

Indexed keywords

MARKETING; PRODUCT DEVELOPMENT; RESEARCH AND DEVELOPMENT MANAGEMENT; SALES; SOCIETIES AND INSTITUTIONS; TECHNOLOGY TRANSFER;

BIOTECH INDUSTRY; LICENSING STRATEGY; TECHNOLOGY-BASED FIRMS;

STRATEGIC PLANNING;

EID: 6444223098     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2004.04.005     Document Type: Article

References (47)

1. Adam Y., Ong C.H., Pearson A.W. Licensing as an alternative to foreign direct investment: an empirical investigation. Journal of Product Innovation Management. 5:1988;32-49.
2. Aldrich H.E., Auster E. Even dwarfs started small: liabilities of size and age and their strategic implications. Research in Organizational Behavior. 8:1986;165-198.
3. Anand B.N., Khanna T. The structure of licensing contracts. Journal of Industrial Economics. 48:2000;103-135.
4. Autio E. New technology-based firms as agents of R&D and innovation: an empirical study. Technovation. 14:1994;259-273.
5. Autio E. Atomistic and systemic approaches to research on new technology-based firms: a literature study. Small Business Economics. 9:1997;195-209.
6. Baier, W., Pleschak, F. (Hrsg.), 1996. Marketing und Finanzierung junger Technologieunternehmen: den Gründungserfolg sichern. Gabler, Wiesbaden, Germany.
7. Brockhoff K. Funktionsbereichsstrategien, Wettbewerbsvorteile und Bewertungskriterien: Eine empirische Untersuchung am Beispiel der Biotechnologie. Zeitschrift für Betriebswirtschaft. 60(4):1990;451-472.
8. Budak P.R., Susbauer J.C. International expansion through licensing: guidelines for the small firm. Journal of Small Business Management. 15(1):1977;17-21.
9. Chakrabarti A.K., Weisenfeld U. An empirical analysis of innovation strategies of biotechnology firms in the US. Journal of Engineering and Technology Management. 8(3/4):1991;243-260.
10. Churchill, N.C., Lewis, V.L., 1983. The five stages of small business growth. Harvard Business Review, 33-50.
11. Deeds D.L., Hill C.W.L. Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms. Journal of Business Venturing. 11:1996;41-55.
12. Dibner, M.D., 1999. Biotechnology Guide U.S.A., 5th ed. Macmillan Reference, London.
13. Fontes M., Coombs R. Contribution of new technology-based firms to the strengthening of technological capabilities in intermediate economies. Research Policy. 30:2001;79-97.
14. Ford, D., 1985. The management and marketing of technology. In: Lamb, R., Shrivastava, P. (Eds.), Advances in Strategic Management, vol. 3. Jai Press, London, pp. 103-134.
15. Ford D., Ryan C. Taking technology to market. Harvard Business Review. 59:1981;117-126.
16. Freeman C. Networks of innovators: a synthesis of research issues. Research Policy. 20:1991;499-514.
17. Greiner, L.E., 1972. Evolution and revolution as organizations grow. Harvard Business Review, 37-46.
18. Greipl, E., Täger, U.C., 1982. Wettbewerbswirkungen der unternehmerischen Patent- und Lizenzpolitik unter besonderer Berücksichtigung kleiner und mittlerer Unternehmen. Duncker & Humblot, Berlin.
19. Hagedoorn J. Understanding the rationale of strategic technology partnering: interorganizational modes of cooperation and sectoral differences. Strategic Management Journal. 14:1993;371-385.
20. Hamman, P., Mittag, H., 1986. The marketing of industrial technology through licensing. In: Backhaus, K., Wilson, D.T. (Eds.), Industrial Marketing - A German-American Perspective. Springer, Berlin, pp. 224-242.
21. Hoang, H., 2001, The determinants and evolution of new entrant-incumbent alliances: a study of cooperative interactions in the biopharmaceutical industry. Working paper.
22. Lerner J., Merges R.P. The control of technology alliances: an empirical analysis of the biotechnology industry. Journal of Industrial Economics. 46:1998;125-156.
23. McGee J.E., Dowling M.J., Megginson W.L. Cooperative strategy and new venture performance: the role of business strategy and management experience. Strategic Management Journal. 16:1995;565-580.
24. Miles, R.E., Snow, C.C., 1978. Organizational Strategy, Structure, and Process. McGraw-Hill, New York.
25. Mintzberg H. Patterns in strategy formation. Management Science. 24(9):1978;934-948.
26. Mintzberg H., McHugh A. Strategy formation in an adhocracy. Administrative Science Quarterly. 30:1985;160-197.
27. Mittag, H., 1985. Technologiemarketing: Die Vermarktung von industriellem Wissen unter besonderer Berücksichtigung des Einsatzes von Lizenzen. Brockmeyer, Bochum.
28. Mordhorst, C.F., 1994. Ziele und Erfolg unternehmerischer Lizenzstrategien. Deutscher Universitäts-Verlag, Wiesbaden.
29. Oakey R. High technology small firms: their potential for rapid industrial growth. International Small Business Journal. 9(4):1991;31-42.
30. O'Farrell P.N., Hitchens D.M.W.N. Alternative theories of small-firm growth: a critical review. Environment and Planning. 20:1988;1365-1383.
31. Pisano G. The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Policy. 20:1991;237-249.
32. Powell, W.W., Koput, K.W., Smith-Doerr, L., Owen-Smith, J., 1999. Network position and firm performance: organizational returns to collaboration in the biotechnology industry. In: Andrews, S., Knoke, D. (Eds.), Networks In and Around Organizations. Jai Press.
33. Prahalad, C.K., Hamel, G., 1990. The core competence of the corporation. Harvard Business Review, 79-91.
34. Rivette, K.G., Kline, D., 2000. Discovering new value in intellectual property. Harvard Business Review, 54-66.
35. Roche, K., 2002. Alliance watch: focus on 2001's biotech Megadeals, Vivo: The Business and Medicine Report, January, p. 8.
36. Smith H.L., Dickson K., Smith S.L. 'There are two sides to every story': innovation and collaboration within networks of large and small firms. Research Policy. 20:1991;457-468.
37. Stankiewicz R. Spin-off companies from universities. Science and Public Policy. 21(2):1994;99-107.
38. Stinchcombe, A.L., 1965. Social structure and organizations. In: March, J.G. (Ed.), Handbook of Organizations. Rand McNally & Company, Chicago, pp. 142-193.
39. Storey D.J., Tether B.S. New technology-based firms in the European union: an introduction. Research Policy. 26:1998;933-946.
40. Stuart T.E. Network positions and propensities to collaborate: an investigation of strategic alliance formation in a high-technology industry. Administrative Science Quarterly. 43(3):1998;668-698.
41. Stuart T.E., Hoang H., Hybels R.C. Interorganizational endorsements and the performance of entrepreneurial ventures. Administrative Science Quarterly. 44(2):1999;315-349.
42. Taylor, C.T., Silberston, Z.A., 1973. The Economic Impact of the Patent System. A Study of the British Experience. Cambridge University Press, Cambridge.
43. Teece D.J. Profiting from technological innovation: implications for integration, collaboration, licensing and public policy. Research Policy. 15:1986;285-305.
44. Teece D.J. Information sharing, innovation, and antitrust. Antitrust Law Journal. 62(2):1994;465-481.
45. Telesio, P., 1979. Technology Licensing and Multinational Enterprises. Praeger, New York.
46. Weisenfeld-Schenk U. Technology strategies and the Miles & Snow typology: a study of the biotechnology industry. R&D Management. 24(1):1994;57-64.
47. Ziemer M. Chemical firms report in survey. Les Nouvelles. 26(3):1991;113-116.